NCT07400003: Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 519 planned
- Started
- 6 Jan 2026
- Primary completion
- 31 May 2026
- Arms
- High-dose group
- Results
- None posted
- 6 Jan 2026: Trial started
- 10 Feb 2026: Trial registered